COMMUNIQUÉS West-GlobeNewswire

-
Ultimovacs ASA: Cancellation of subsequent repair offering
13/02/2025 -
Nutrify Today C-Suite Sumflex 2025 Shaping the Future of Nutraceuticals
13/02/2025 -
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
13/02/2025 -
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
13/02/2025 -
Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
13/02/2025 -
USOSM Expands Best-in-Class Network of Premier Oral and Maxillofacial Surgeons
13/02/2025 -
Author Andrew Leland Receives 2025 Helen Keller Achievement Award
13/02/2025 -
Idorsia publishes the resolutions for the upcoming bondholder meeting
12/02/2025 -
Illuccix® Approved in the United Kingdom
12/02/2025 -
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit
12/02/2025 -
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
12/02/2025 -
Voting Rights and Shares Capital of the Company
12/02/2025 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
12/02/2025 -
Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors
12/02/2025 -
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time
12/02/2025 -
Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs
12/02/2025 -
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
12/02/2025 -
Amwell® Announces Results for Fourth Quarter and Full Year 2024
12/02/2025 -
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
12/02/2025
Pages